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Abstract: Frey syndrome is a widely recognized sequela
of parotidectomy with a variable prevalence dependent upon
diagnostic criteria. There exists a multitude of strategies for
both prevention and treatment. Surgeons are obligated to
engage patients in a frank and open discussion of the opera-
tive risks, benefits, and alternatives. Due to uncertainty regard-
ing the significance of Frey syndrome postoperatively, the
process of informed consent and preoperative decision-mak-
ing pose a potential ethical quandary. This commentary is
designed to heighten the awareness of the preoperative
informed consent process by dissecting the ethical tenets
underlying these patient encounters using Frey syndrome as
an example, ensuring that patients are granted the opportunity
to participate in their own care in accordance with the concept
of individual autonomy. VC 2010 Wiley Periodicals, Inc. Head
Neck 32: 1125–1128, 2010
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Frey syndrome describes the phenomenon of
sweating and hyperemia of the facial skin occur-
ring during mastication. It typically occurs after
parotidectomy for benign or malignant condi-
tions, but may occur with any event (trauma,
infection, and so on) that disrupts the parotid
bed. The eponym honors Lucja Frey, the Polish
neurologist who originally described its patho-
physiology. The pathway involves parasympa-
thetic fibers aberrantly reinnervating sweat
glands and the subcutaneous vascular plexus
rather than their original end-organ, the secre-
tomotor cells of the parotid acini.1
The diagnosis of Frey syndrome after paroti-
dectomy is controversial; its incidence varies
depending upon diagnostic criteria. While objec-
tive testing indicates an extremely high preva-
lence, fewer patients report symptoms.
Preventive and treatment strategies are wide-
ranging. There is a dearth of quality data
regarding the efficacy of various strategies for
the prevention of Frey syndrome; no randomized
or prospectively controlled studies have been
published. This article does not purport to pro-
vide a comprehensive discussion of the various
strategies for prevention of and treatment for
Frey syndrome; the interested reader is referred
to published reviews on this topic.2
Due to the unique facets of the condition and
its management, Frey syndrome poses an
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interesting model for a discussion of medical
ethics with regard to surgical decision-making.
To what extent should Frey syndrome be men-
tioned as a potential postoperative sequela given
its near-ubiquity on objective tests and a lack of
consensus regarding its actual impact upon
patients? This article will attempt to define the
controversies inherent to the discussion and dis-
sect the ethical questions posed with regard to
patient autonomy, the informed consent process,
and patient involvement in preoperative deci-
sion-making.
The Diagnostic Conundrum. Objective measure-
ments of Frey syndrome typically involve a ver-
sion of the starch-iodine test originally
described by Minor,3 in which gustatory sweat-
ing causes a color change on the involved skin.
Subjective reports of Frey syndrome are less
straightforward. In surveys retrospectively ask-
ing postoperative patients about their symp-
toms, the reported incidence of Frey syndrome
varies. In a review of 7 studies totaling 542
patients, the average rates of objective and sub-
jective Frey syndrome, respectively, were 79%
and 40%.4 Another review article estimates a
positive starch-iodine test in 95%, an affirmative
answer to direct questioning in 35%, and unsoli-
cited complaints in 10%.2
There is no ideal, validated instrument spe-
cifically designed to assess the impact of Frey
syndrome upon quality of life. In a quality of life
study that evaluated Frey syndrome, postopera-
tive parotidectomy patients averaged a score of
93 on a 0 to 100 scale, with 0 representing intol-
erable symptoms of erythema and sweating, and
100 representing no symptoms.5 Another study
attempted to describe severity based upon the
degree of the patients’ symptoms and the
affected surface area, using a numerical scale to
subdivide ‘‘mild’’ versus ‘‘severe’’ Frey syndrome;
slightly more than half were rated as severe.4 A
group of 173 postparotidectomy patients (of
whom 13% developed subjective Frey syndrome)
were asked an open-ended question about what
they would change about their perioperative ex-
perience; 8% reported that ‘‘more information’’
would have been helpful.6
In general, Frey syndrome is likely under-rec-
ognized and under-reported. Some authors report
that Frey syndrome is brought to the attention of
medical providers only when patients are asked
specifically about related symptoms. Designing a
study to measure the percentage of patients who
complain of Frey syndrome without prompting
would be quite difficult from a methodologic
standpoint. However, examining the number of
patients who choose to undergo treatment of the
condition sheds light onto this issue. One of the
few articles to report this data estimated that 5%
to 10% of patients request management of symp-
tomatic Frey syndrome.7
Autonomy and Informed Consent. The overriding
theme with regard to contemporary medical
ethics involves the respect for patient autonomy,
in which patients serve as active decision-
makers in their own care, eschewing the historic
tradition of paternalism. Legally, this was estab-
lished by a decision of the New York Court of
Appeals in 1914, stating that ‘‘every human
being of adult years and sound mind has a right
to determine what shall be done with his own
body.’’8 The development of the doctor-patient
relationship underlies all such encounters.
Parker9 describes a model involving the creation
of a partnership between physician and patient
with honest, open lines of communication,
coupled with deliberation of choices, alterna-
tives, and outcomes, with both clinician’s and
patient’s input, assimilated into a workable and
practical solution that is in accordance with the
patient’s preferences.
The concept of preoperative informed consent
is descended from the theme of patient
autonomy. Patients with sufficient capacity are
expected to be engaged in a conversation involv-
ing the risks and benefits of, and viable alterna-
tives to, a proposed intervention. While medical
providers should participate in this decision-
making process with their patients, including
providing medical opinions based upon their
own expertise, the decision itself rests with the
patient or their designated proxy. The consent
process begins with the determination of
capacity, and does not end with a signature on a
consent form, but rather encompasses the entire
process whereby patients and care providers
engage in an ongoing discussion of their care.10
In the United States, obtaining surgical con-
sent has been mandated through the courts.
While legal matters are of obvious importance,
they are secondary to the crux of the physician–
patient partnership. From an ethical standpoint,
disclosure of risk is in many ways relative to
the nature of the consequence itself. Thus, rare
but dire complications (such as facial nerve
transection) should be discussed. If a sequela
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has more trivial consequences but is relatively
common (ie, a numb earlobe after parotidec-
tomy), it may be discussed at the discretion of
the surgeon. Frey syndrome poses a quandary
given uncertainty with regard to both incidence
and perceived severity.
Patients do not always understand or retain
the information provided during the consenting
process, despite the best efforts of the individual
obtaining consent. In a study by Hekkenberg et
al,11 the overall recall rate of complications from
a preoperative discussion of the risks of head
and neck surgery was 48%. In patients under-
going parotidectomy, only 27% of patients
remembered the risk of Frey syndrome 2
months after their surgery. Poor recollection is
not always related to seemingly unlikely compli-
cations; in the same study, only 19% of patients
undergoing thyroid/parathyroid surgery recalled
the possibility of having an unsightly scar.
One might argue that Frey syndrome is only
significant if it is noticed by the patient, while
others might contend that it is only truly worth
discussing if patients not only notice its pres-
ence, but are bothered by it. In this case, it is
worth mentioning simply so that patients are
not scared or confused by its presence, espe-
cially if its etiology is not immediately apparent.
Patients may not complain of Frey syndrome
postoperatively simply due to the fact that they
do not associate it with their surgery; often, it
develops months after surgery, and even when
counseled preoperatively, the majority of
patients do not remember it being mentioned as
a potential risk.
Patient Roles in Operative Decisions. There are
practical limitations with regard to preoperative
informed consent. Minute details of a surgical
procedure (the decision to tie or clip vessels, for
example) are reasonably expected to be inherent
to the procedure itself and left to the discretion
of the surgeon. In contrast, major decisions (the
decision to sacrifice a functional facial nerve
involved with neoplasm, for example) typically
require patient involvement. Patient character-
istics also play an important role; those who are
more involved and educated with regard to their
own medical situation may require a more
detailed discussion than patients without such
interest or knowledge. In certain cases, provid-
ing too much information or offering patients an
inordinate number of choices may become over-
whelming or add to their confusion. That said,
while a patient’s ignorance is not an excuse to
circumvent the consent process, these factors
can and should influence the give-and-take of
the doctor–patient relationship.
With regard to prevention strategies for Frey
syndrome, the data concerning efficacy remain
inconclusive. Reported techniques for prevention
involve raising a thicker skin flap, leaving a por-
tion of the parotid gland undissected, tissue rear-
rangements (muscle/fascia flaps), or implanting
autologous, allogeneic, or other biologic materi-
als. Similarly, multiple treatment options exist,
including reassurance, topical or systemic anti-
cholinergics/antiperspirants, subcutaneous injec-
tion of Botulinum toxin, or a variety of surgical
procedures.
Further complicating the discussion is the
fact that some of these strategies are also utilized
to provide an aesthetic improvement in the oper-
ative defect. Many of the recommended preventa-
tive techniques involve inherent risk.
Implantable materials increased the risks of poor
wound healing in one study,12 and the use of any
biologic material carries an inherent theoretical
risk (albeit low) of rejection/extrusion and/or dis-
ease transmission. In addition, local tissue rear-
rangements or flaps that add bulk to the surgical
site might delay early recognition of tumor recur-
rence. An author of 1 of the earlier articles
describing local tissue rearrangements to prevent
Frey syndrome wrote an editorial sharply con-
demning the use of any type of surgical implant
due to the potential risks, which he deemed
unjustified given the rare and minor consequen-
ces of the complication itself.13 Nevertheless, the
absence of quality research obviates a definitive
answer, and surgical practice is largely based
upon individual judgment.
Clearly, there is no accepted consensus
regarding the utility of preoperative prevention
strategies. In these cases, it is imperative to
involve the patients in the discussion. Physi-
cians should explain the rationale behind, in
addition to the risks and benefits of, the various
options to their patients. All options need not be
painstakingly explained so long as patients are
an integral part of the decision-making process
and given sufficient opportunity to exercise their
own autonomy.
Surgeon preference can and should frame the
conversation, as individual surgeon experience
and anecdotal evidence is potentially helpful in
dictating care and informing the treatment para-
digm for clinical questions lacking quality data.
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For example, if a surgeon notices that a larger
proportion of patients are complaining of Frey
syndrome, it may behoove him/her to critically
appraise his/her outcomes and consider changes
in technique or treatment. The senior author of
this article, based upon her personal experience
with approximately 200 parotidectomies over the
past decade, believes that Frey syndrome is com-
mon, bothersome, and preventable in a safe and
efficacious fashion. She routinely recommends
placement of Alloderm (Lifecell, Branchburg,
NJ), and counsels patients regarding the associ-
ated risks, benefits, and uncertainties.
Patients should have the opportunity to weigh
options under their surgeon’s guidance, espe-
cially with regard to comparatively riskier and
unproven strategies such as the use of implant-
able materials. In general, physicians are not
obligated, either ethically or professionally, to
offer unproven and potentially harmful treat-
ments to patients. Thus, any discussion of strat-
egies to prevent Frey syndrome should include a
discussion of their inherent potential risk.
Recommendations. Based upon available data,
Frey syndrome is noticed by a significant num-
ber of patients, and bothersome in an unknown
subset. Nevertheless, patients can and should
expect their surgeons to be honest and forth-
right about what can be reasonably expected in
the postoperative period. Clinicians should be
candid with patients, stressing that Frey syn-
drome is quite common when testing is per-
formed, but that its clinical significance is not
well established. Surgeons should also include
their patients in preoperative decision-making
with regard to deciding upon the use of prevent-
ative strategies for Frey syndrome.
CONCLUSION
Physicians and patients must embark upon a
trust-based partnership in order to foster a
mutually beneficial and ethical relationship.
Patients rely upon the opinions and expertise of
their physicians, and likewise, doctors must rou-
tinely take their patients’ individual preferences
into account. These issues are applicable not
only to Frey syndrome and parotidectomy, but
highlight themes common within the informed
consent process for a wide variety of procedures.
Whereas the slope from autonomy to paternal-
ism may be slippery, we owe it to our patients to
be prudent and sure-footed.
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